Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results
31. März 2022 16:15 ET
|
Interpace Biosciences, Inc.
●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year ●2021 Full Year Net Loss Improved $11.5 Million vs Prior...